XML 107 R89.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:      
Net income (loss)   $ (18,499,000) $ (9,712,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Share-based compensation   12,231,000 4,906,000
Depreciation and amortization   5,390,000 2,406,000
Amortization of right-of-use assets   2,804,000 1,638,000
Change in fair value of derivative warrant liabilities   6,064,000 292,000
Other   107,000 886,000
Changes in operating assets and liabilities:      
Accounts receivable   382,000 (3,386,000)
Prepaid expenses and other assets   (1,031,000) (2,191,000)
Accounts payable   (692,000) (1,683,000)
Accrued expenses and other current liabilities   (399,000) 2,138,000
Accrued compensation and benefits   8,080,000 3,869,000
Operating lease liabilities   (3,536,000) (1,691,000)
Net cash used in operating activities   10,901,000 (2,528,000)
Cash Flows from Investing Activities:      
Cash paid for acquisitions, net of cash acquired     (13,114,000)
Loan to SharesPost     (3,000,000)
Purchases of property and equipment     (13,000)
Capitalized internal-use software development costs   (1,054,000) (1,149,000)
Payment of deferred payments related to IRA Services acquisition     (6,097,000)
Net cash used in investing activities   (3,256,000) (23,373,000)
Cash Flows from Financing Activities:      
Offering costs paid   (4,954,000)  
Proceeds from exercise of options   1,621,000 24,000
Proceeds from notes payable     25,566,000
Repayment of notes payable   (19,438,000) (27,688,000)
Cash paid to purchase equity awards   (23,000) (49,000)
Net cash provided by financing activities   26,581,000 39,380,000
Net change in cash   34,226,000 13,479,000
Supplemental disclosures of cash flow information:      
Cash paid for interest   2,118,000 425,000
Supplemental disclosure of noncash financing activities:      
Deferred payments related to SharesPost acquisition     783,000
Forgiveness of loan to SharesPost in relation to acquisition     3,000,000
Issuance of Junior convertible preferred stock in relation to SharesPost acquisition     20,383,000
Issuance of Junior convertible preferred stock warrants in relation to SharesPost acquisition     1,285,000
Issuance of Class AA common stock in relation to SharesPost acquisition     44,817,000
Exchange of Class AA common stock for Series B convertible preferred stock   39,722,000  
Conversion of convertible notes into Series B-1 convertible preferred stock   111,000 9,940,000
Vesting of early exercised stock options and restricted stock awards   145,000 32,000
Warrant issued in connection with issuance of term loan     151,000
Warrant issued in connection with issuance of convertible notes payable     51,000
Motive Capital      
Cash Flows from Operating Activities:      
Net income (loss) $ (11,799,629) 9,363,744  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Transaction cost - derivative liabilities 1,126,070    
Change in fair value of derivative warrant liabilities 10,659,080 (16,101,880)  
Gain on marketable securities, dividends and interest held in Trust Account (20,525) (90,914)  
Changes in operating assets and liabilities:      
Prepaid expenses (651,605) 377,371  
Accounts payable 961 4,357,744  
Accrued expenses 5,560 674,011  
Net cash used in operating activities (680,088) (1,419,924)  
Cash Flows from Investing Activities:      
Cash deposited in Trust Account (414,000,000)    
Net cash used in investing activities (414,000,000)    
Cash Flows from Financing Activities:      
Repayment of note payable to related parties (130,492)    
Proceeds received from initial public offering, gross 414,000,000    
Offering costs paid (8,619,770)    
Proceeds received from private placement 11,080,000    
Proceeds from issuance of ordinary shares to initial shareholders 25,000    
Net cash provided by financing activities 416,354,738    
Net change in cash 1,674,650 (1,419,924)  
Cash - beginning of the period 0 1,674,650  
Cash - end of the period 1,674,650 $ 254,726 $ 1,674,650
Supplemental disclosure of noncash financing activities:      
Deferred underwriting commissions charged to additional paid-in capital in connection with initial public offering 14,490,000    
Offering costs included in accrued expenses 410,000    
Offering costs charged to additional paid-in capital in connection with the initial public offering $ 880,262